22nd Century Group XXII

$ 2.06 7.85%

Annual report 2025
added 03-26-2026

22nd Century Group DIO Ratio 2011-2026 | XXII

Annual DIO Ratio 22nd Century Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
114	81.3	51.8	47.9	30.4	27.8	32	43.5	69.2	88.8	109	1.51 K	1.11 K	6.61 K	592

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.61 K	27.8	701

Quarterly DIO Ratio 22nd Century Group

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
96.5	80.6	72.3	-	73.6	65.5	78.3	-	352	242	198	-	54.2	46.2	34.6	-	30.4	25.6	30.9	-	26.7	29.8	29	-	31.9	35	37.9	-	45.5	41.1	47.8	-	61.5	73.7	-	-	-	-	-	-	83.7	-	-	-	616	-	-	-	6.24 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6.24 K	25.6	306

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 320.13	-3.98 %	$ 41.9 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.81	0.6 %	$ 1.02 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.35	-12.9 %	$ 347 M	USA
	Aquestive Therapeutics AQST	120	$ 4.26	0.47 %	$ 456 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.19	-1.59 %	$ 3.08 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.61	8.05 %	$ 428 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA